Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Pinterest, Inc. (NASDAQ:PINS) reported that its Chief Legal and Business Affairs Officer, Walcott Wanjiku Juanita, completed a transaction involving the sale of 14,208 shares of the company's Class A Common Stock. Executed on June 24, 2026, the sale generated approximately $279,187 in proceeds, with each share transacted at a price of $19.65. The t…
Douglas L Soder, Executive Vice President and President of the Commercial Sector at TTM Technologies Inc. (NASDAQ:TTMI), executed a sale of 8,902 shares of the company's common stock on June 23, 2026. The transaction, valued at approximately $1.87 million, was conducted under a pre-arranged 10b5-1 trading plan established on February 24, 2026. Sode…
Mittie Doyle, Chief Medical Officer at Avalo Therapeutics, Inc. (NASDAQ: AVTX), has sold 1,450 shares of common stock for a total value of $26,100 on June 23, 2026. The transaction was executed as part of a pre-arranged Rule 10b5-1 trading plan adopted on November 13, 2025. Prior to the sale, Doyle exercised stock options to acquire the shares at $…
Director Christopher D. Brown executed a sale of 9,900 shares in 908 Devices Inc. (NASDAQ: MASS) under a pre-arranged trading plan. The transaction took place as the company's stock approached its 52-week peak, even though recent financial results showed a significant earnings per share miss. The sale reduces Brown's direct holdings but remains par…
Kevin J. Knopp, President and CEO of 908 Devices Inc. (NASDAQ: MASS), has sold a total of 60,345 shares of the company's common stock in a series of transactions executed between June 23 and June 25, 2026. The sales, which totaled $550,624, were conducted under a pre-arranged Rule 10b5-1 trading plan established in May 2025. This executive activity…
Christopher Hite, Executive Vice President and Chairman of Partnering at Royalty Pharma plc (NASDAQ:RPRX), executed a series of share sales totaling $8,159,276 on June 23, 2026. The transactions, conducted under a pre-arranged 10b5-1 trading plan, involved the disposal of 150,000 Class A Ordinary Shares at prices between $53.39 and $54.94. This act…
Todd Dzyak, Chief Operating Officer at WidePoint Corp. (NASDAQ:WYY), executed a direct sale of 10,000 shares on June 25, 2026, realizing $240,000 at a price of $24.00 per share. This transaction reduces his direct ownership to 115,436 shares, though he retains derivative securities through stock options. The sale follows a significant 414% surge in…
Live Oak Bancshares, Inc. (NASDAQ: LOB) director William L. Williams III sold 8,400 shares of voting common stock on June 24, 2026, generating $336,453 in proceeds. The sale was executed through a Rule 10b5-1 trading plan adopted in March 2026 and shares were held in the William L. Williams Revocable Trust. Following the transaction, Williams maint…
Raymond E. Scott, President and CEO of Lear Corp (NASDAQ: LEA), executed a series of transactions on June 24, 2026, resulting in the sale of 50,000 shares of the company's common stock. The total proceeds from these sales amounted to approximately $6,768,451, with the weighted average price per share falling between $134.441 and $137.211. The trans…
Josh Folds, Chief Banking Officer at FB Bancorp, Inc. (NASDAQ:FBLA), executed a sale of 1,110 shares of the company's common stock on June 22, 2026, realizing proceeds of $16,150. The transaction occurred at a price of $14.55 per share. Following this divestment, Folds continues to hold a substantial direct stake in the company, alongside indirect …
CoreWeave CEO Michael Intrator executed a substantial divestment of 307,692 Class A Common Stock shares on June 23, 2026, totaling $32,865,847. The transactions, facilitated through a Rule 10b5-1 trading plan, were carried out at weighted average prices between $102.7157 and $111.8039 per share. This sale occurs as CoreWeave's share price has retre…
Thomas R. Cellitti, a director at Core Molding Technologies Inc. (NASDAQ:CMT), executed three separate sales of common stock between June 23 and June 25, 2026. The transactions resulted in a total value of approximately $33,970, with share prices ranging from $24.0 to $24.0662. Following these sales, Cellitti retains a direct holding of 92,393 shar…
Prospect Capital Corp (NASDAQ:PSEC) Chief Executive Officer John F. Barry has executed a significant purchase of company equity, acquiring over one million shares in late June 2026. The acquisition, valued at approximately $2.43 million, occurs against a backdrop of recent portfolio adjustments, including the announced sale of a subsidiary to MYR G…
Clean Energy Fuels Corp. (NASDAQ:CLNE) director Stephen Scully executed a recent acquisition of the company's equity, purchasing 25,000 shares on June 25, 2026. The transaction valued at $43,725 occurred while the stock was trading near its 52-week low. This insider activity follows a quarter where Clean Energy Fuels reported financial results that…
Susan M. Byrne, serving as Director Emerita at Westwood Holdings Group Inc. (NASDAQ: WHG), executed a series of stock sales totaling $79,041 over three consecutive trading days in June. These transactions were facilitated through a Rule 10b5-1 trading plan established earlier in the year. The sales occurred while WHG shares were trading close to th…
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), executed a sale of 9,500 shares of common stock valued at $5,212,519 on June 24, 2026. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on November 7, 2025. This sale followed the acquisition of an equal number of shares through the ex…
Scott Bizily, serving as the Chief Legal Officer for 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), executed a significant divestment of company equity on June 23, 2026. The transaction involved the sale of 9,810 shares of common stock, generating proceeds of $117,720 at a share price of $12.00. This disposition occurred immediately following the e…
Christy Jones, a director at Beta Bionics, Inc. (NASDAQ:BBNX), executed a sale of 1,406 shares of the company's common stock on June 24, 2026. The transaction, valued at $21,090 based on a price of $15.0 per share, was conducted under a Rule 10b5-1 trading plan adopted on February 19, 2026. Following this divestment, Jones retains direct ownership …
Mark Hopman, Chief Commercial Officer at Beta Bionics, Inc. (NASDAQ:BBNX), executed a sale of 1,258 shares of the company's common stock on June 24, 2026, totaling $18,880. The transaction was facilitated through a Rule 10b5-1 trading plan established on May 13, 2025, with shares sold at prices between $15.00 and $15.015, yielding a weighted averag…
Josh Silverman, serving as Executive Chair of the Board at Etsy Inc., executed a significant divestiture of company equity on June 24, 2026. The transaction involved the sale of 97,389 common shares, generating gross proceeds of $7,693,731. This activity was facilitated through the exercise of employee stock options, which were acquired at a base p…
Michael Adam Leggett, Senior Vice President and Chief Supply Chain Officer at La-Z-Boy, executed a series of share transactions in late June 2026. The executive sold a significant portion of his holdings, with the most recent transaction totaling nearly $375,000. This activity occurs against a backdrop of strong recent stock performance and a fisca…
JoEllen Legg, a director at Reaves Utility Income Fund (NASDAQ: UTG), has increased her personal stake in the fund by purchasing an additional $24,719 worth of common shares of beneficial interest. The transaction, reported via a recent Securities and Exchange Commission (SEC) filing, occurred on June 24, 2026. This purchase brings her total direct…
Halim Dhanidina, a director at Fidelity National Financial, Inc. (NASDAQ:FNF), executed a significant sale of company stock on June 24, 2026. The transaction reduces his direct holdings and coincides with the company's recent financial reporting and product developments. This analysis examines the insider activity alongside the company's market val…
Oscar Health, Inc. (NASDAQ:OSCR) reported significant insider activity as director Mario Schlosser executed a series of stock sales totaling approximately $30.18 million. The transactions, conducted on June 23, 2026, involved the direct sale of over one million shares and the conversion of Class B Common Stock into Class A shares. Despite the subst…
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) director William D. Waddill has executed a significant stock sale, moving 9,000 shares of the company's common stock. The transaction, valued at $1,061,460, was carried out under a pre-arranged 10b5-1 trading plan established earlier in the year. This sale coincides with a period of elevated trading act…
